Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: A systematic review of randomized controlled trials

Maturitas

Volumn 75, Issue 4, 2013, Pages 341-348

  Yang, Z D ^a   Yu, J ^b   Zhang, Q ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First People's Hospital of Jiujiang City   (China)

Author keywords

Climacteric syndrome; Cognition; Menopause; Raloxifene

Indexed keywords

ESTROGEN; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ALZHEIMER DISEASE; ANXIETY DISORDER; BIBLIOGRAPHIC DATABASE; COCHRANE LIBRARY; COGNITION; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; FEMALE; HAMILTON SCALE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; JADAD SCORE; MEDLINE; MENOPAUSAL SYNDROME; MENOPAUSE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; PATIENT SELECTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REVIEW; RISK FACTOR; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SLEEP; SLEEP DISORDER; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VAGINAL DRYNESS; VASOMOTOR DISORDER; VERBAL MEMORY; COGNITION DISORDERS; DRUG EFFECTS; MEMORY; REPRODUCTIVE HEALTH;

ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MEMORY; MENOPAUSE; MENTAL HEALTH; RALOXIFENE; REPRODUCTIVE HEALTH; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SLEEP;

EID: 84880287213     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.05.010     Document Type: Review

References (24)

1. S.Q. Lin, L.Z. Sun, and J.F. Lin Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women Climacteric 14 4 2011 472 481
2. E. Banks, and K. Canfell Invited commentary: hormone therapy risks and benefits - the women's health initiative findings and the postmenopausal estrogen timing hypothesis American Journal of Epidemiology 170 2009 24 28
3. R.S. Blumenthal, B. Baranowski, and S.A. Dowsett Cardiovascular effects of raloxifene: the arterial and venous systems American Heart Journal 147 2004 783 789 (Pubitemid 38880982)
4. P. Collins, P. Mosca, and M.J. Geiger Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors Circulation 119 2009 922 930
5. S. Konyalioglu, G. Durmaz, and A. Yalcin The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats Cell Biochemistry and Function 25 3 2007 259 266 (Pubitemid 46827121)
6. V.K. Todorova, Y. Kaufmann, S. Luo, and V.S. Klimberg Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake Cancer Chemotherapy and Pharmacology 67 2 2011 285 291
7. S.S. Ko, and V.C. Jordan Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene Expert Opinion on Pharmacotherapy 12 4 2011 657 674
8. V.G. Vogel, J.P. Costantino, and D.L. Wickerham Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer Cancer Prevention Research 3 2010 696 706
9. B.W. Walsh, L.H. Kuller, and R.A. Wild Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women JAMA 279 1998 1445 1451
10. T. Simoncini, A.R. Genazzani, and J.K. Liao Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene Circulation 105 2002 1368 1373 (Pubitemid 34260430)
11. Y. Kasai, M. Maegawa, and S. Yamamoto Effects of raloxifene on the production of cytokines in stimulated whole blood in ex vivo and in vitro studies Journal of Medical Investigation 58 2011 110 117
12. Eli Lilly and Company Evista prescribing information 2011
13. J.G. Buckwalter, A.M. Geiger, and T.D. Parsons Cognitive effects of short-term use of raloxifene: a randomized clinical trial International Journal of Neuroscience 117 2007 1579 1590 (Pubitemid 47537043)
14. K. Yaffe, K. Krueger, and S.R. Cummings Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the multiple outcomes of raloxifene evaluation (MORE) randomized trial American Journal of Psychiatry 162 2005 683 690 (Pubitemid 40489129)
15. V. Natale, P. Albertazzi, N. Missiroli, D. Pedrini, and M. Salgarello Effects of raloxifene on mood, sleep, libido and cognitive function in postmenopausal healthy women: a pilot study Maturitas 48 2004 59 63 (Pubitemid 38829107)
16. R. Strickler, D.W. Stovall, D. Merritt, W. Shen, M. Wong, and S.L. Silfen Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial Obstetrics and Gynecology 96 2000 359 365
17. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17 1996 1 12 (Pubitemid 26120810)
18. T. Nickelsen, E.G. Lufkin, B.L. Riggs, D.A. Cox, and T.H. Crook Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women Psychoneuroendocrinology 24 1999 115 128 (Pubitemid 29057023)
19. N.B. Jarkova, F. Martenyi, and D. Masanauskaite Mood effect of raloxifene in postmenopausal women Maturitas 42 2002 71 75 (Pubitemid 34521724)
20. F. Modugno, R.B. Ness, S. Ewing, and J.A. Cauley Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis Obstetrics and Gynecology 101 2003 353 361 (Pubitemid 36170138)
21. B. Kessel, L. Nacbtigall, L. Plouffe, S. Siddhanti, A. Rosen, and A. Parsons Effect of raloxifene on sexual function in postmenopausal women Climacteric 6 3 2003 248 256 (Pubitemid 37188285)
22. D.E. Jacobsen, M.M. Samson, M.H. Emmelot-Vonk, and H.J. Verhaar Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial Menopause 17 2 2010 309 314
23. L.J. Black, M. Sato, and E.R. Rowley Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats Journal of Clinical Investigation 93 1994 63 69 (Pubitemid 24030821)
24. J.W. Simpkins, and M. Singh More than a decade of estrogen neuroprotection Alzheimers Dement 4 Suppl. 1 2008 S131 S136